You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADVM-022-04

Showing 1 - 25 of 1,575
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Enrolling by invitation
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • ADVM-022
  • Beverly Hills, California
  • +6 more
Nov 4, 2022

Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of

Active, not recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 6E11 vg/eye of ADVM-022
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 10, 2022

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +10 more
Mar 21, 2022

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +8 more
Dec 23, 2021

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Herpes Zoster Trial in Tartu (HZ/su vaccine)

Recruiting
  • Herpes Zoster
  • HZ/su vaccine
  • Elkridge, Maryland
  • +47 more
Jan 6, 2023

Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Adelaide, Australia
  • +3 more
Jan 30, 2023

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

Recruiting
  • Rectal Cancer
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 11, 2023

Systemic Lupus Erythematosus Trial in China (ICP-022, Placebos)

Completed
  • Systemic Lupus Erythematosus
  • Bengbu, Anhui, China
  • +10 more
Nov 28, 2022

Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

Recruiting
  • Tumor, Solid
  • Radiation: 18F-AlF-FAPi-04
  • Radiation: 18F-FDG
  • Nanchong, Sichuan, China
    Affiliated Hospital of North Sichuan Medical College
Nov 6, 2023

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Necrotic Pulp Trial (Root canal instrumentation EdgeFile X7 to size #35/0.06, Root canal instrumentation EdgeFile X7 to size

Not yet recruiting
  • Necrotic Pulp
  • Root canal instrumentation EdgeFile X7 to size #35/0.06
  • +3 more
  • (no location specified)
Nov 16, 2022

Mantle Cell Lymphoma Trial in China (ICP-022)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +30 more
Jul 5, 2022

Microcystic Lymphatic Malformation Trial in United States (PTX-022)

Recruiting
  • Microcystic Lymphatic Malformation
  • Little Rock, Arkansas
  • +5 more
Feb 25, 2022

Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

Recruiting
  • Papulopustular Rosacea
  • Lotilaner Gel, 2.0%
  • Vehicle control gel
  • Oakville, Ontario, Canada
  • +4 more
Apr 20, 2023

18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

Completed
  • 18F-FAPI
  • +4 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
May 31, 2023

Oral Carcinoma Trial in Beijing (68Ga-FAPI-04)

Recruiting
  • Oral Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Oct 26, 2022

CLL/SLL Trial in China (ICP-022)

Active, not recruiting
  • CLL/SLL
  • Hefei, Anhui, China
  • +24 more
Jul 5, 2022

Low Back Pain, Sciatica Trial in Petach Tikva (BOL-DP-o-04 + SCO, Placebo + SCO)

Completed
  • Low Back Pain
  • Sciatica
  • BOL-DP-o-04 + SCO
  • Placebo + SCO
  • Petach Tikva, Israel
    Beilinson Medical Center
Dec 7, 2022

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

Recruiting
  • Myocardial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
May 11, 2023

Pachyonychia Congenita Trial in United States (PTX-022)

Active, not recruiting
  • Pachyonychia Congenita
  • Phoenix, Arizona
  • +3 more
Dec 2, 2021

Pachyonychia Congenita Trial in New Brighton (PTX-022)

Recruiting
  • Pachyonychia Congenita
  • New Brighton, Minnesota
    Minnesota Clinical Study Center
Dec 1, 2022